Latest Revenue Growth News

Qoria Limited is moving towards a transformative merger with US-based Aura Consolidated Group, Inc., combining complementary digital safety platforms and targeting growth through a $100 million capital raise and ASX listing.

Neuren Pharmaceuticals reported a 15% rise in 2025 royalties from DAYBUE®, boosted by strong US sales and a new powder formulation launch. The company is progressing its pivotal Phase 3 trial for NNZ-2591 in Phelan-McDermid syndrome and reassessing capital management amid solid cash reserves.

Dicker Data has outperformed its FY25 guidance, delivering a 14.9% jump in gross revenue to $3.876 billion, fuelled by AI deals and infrastructure refreshes. The company’s FY26 outlook anticipates continued momentum in AI and data centre projects despite pricing pressures.

Knosys has locked in a two-year, $3.8 million contract extension with ANZ, with full payment received upfront. This deal underpins Knosys’s role in ANZ’s AI integration efforts and strengthens the company’s cash position.

Ainsworth Game Technology posted a 10% revenue increase in FY25 to $291 million, driven by strong Asia Pacific growth, while North American challenges weigh on H1 2026 outlook.

Web Travel Group (ASX:WEB) reported a standout FY26, driven by its WebBeds B2B platform’s 20% TTV growth and 24% EBITDA increase, while redeeming $250 million convertible notes and releasing its inaugural climate-focused Sustainability Report.

PaySauce has successfully launched its Global Payroll Platform in Australia, targeting nearly 700,000 micro-businesses, supported by a $5 million capital raise and steady growth in its New Zealand operations.

CleanSpace Holdings expects modest revenue growth for FY26, hindered by product certification delays and global market challenges, while maintaining a strong cash position and preparing a new respirator launch.

Millennium & Copthorne Hotels New Zealand (MCK) posted robust 2025 revenue gains driven by acquisitions and refurbishments, yet signals a cautious outlook for 2026 as geopolitical tensions and rising costs cloud the horizon.

Adveritas Limited’s annualised recurring revenue (ARR) has surged to $16.3 million, driven by rapid organic growth of its SME self-serve platform and expanding North American footprint beyond gaming.

Fredon, the electrical and mechanical arm of NRW Holdings (ASX:NWH), has secured $120 million in new contracts across Victoria and Western Australia, reinforcing its role in critical infrastructure projects.

Osteopore has secured Hainan FDA approval to clinically use and sell its custom orthopaedic devices at Shanghai Ruijin Hospital’s Hainan branch, marking a key step towards wider China market access. The company has scheduled its first patient surgery for June 2026.